红细胞生成素对异基因造血干细胞移植后患者血常规的影响

原文传递

导出

作者刘启发孙竞孟凡义张钰郑维扬刘晓力徐兵冯茹周淑芸

机构地区第一军医大学南方医院

出处《中华血液学杂志》 CAS CSCD 北大核心 2004年第2期107-108,共2页 Chinese Journal of Hematology

关键词红细胞生成素异基因造血干细胞移植贫血成分输血移植物抗宿主病

参考文献5

1Beguin Y,Clemons GK,Oris R,et al.Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants[].Blood.1991
2Abedi MR,Backman L,Bostrom L,et al.Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation[].Bone Marrow Transplantation.1990
3Beguin Y,Oris R,Fillet G.Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants[].Bone Marrow Transplantation.1993
4Baron F,Sautois B,Baudoux E,et al.Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation[].Experimental Hematology.2002
5Locatelli F,Zecca M,Ponchio L,et al.Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation[].Bone Marrow Transplantation.1994

中华血液学杂志

2004年第2期

内容加载中请稍等...